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Abstract
Milk is known for its high nutrient content that helps to maintain important body functions. 
In this regard, bioactive peptides that are encrypted in milk proteins and get released during 
processing and/or digestion might play a role. These peptides are able to inhibit enzymes, 
influence cell growth, or target specific receptors. The peptide profile that arises after pro-
tein digestion in the jejunum before the absorption into the blood takes place includes 
these bioactive peptides. The composition of the peptide profile is influenced strongly via 
processing and a modification in processing might target specific functionalities. Thermal, 
chemical, biochemical, and physical treatments affect protein digestion mainly by changing 
the protein structure for example via denaturation or protease actions. Parameters influ-
encing this are external ones, like the matrix of the product, and internal ones, like specific 
enzyme deficiencies. However, considering all the important aspects that are involved, there 
might be the possibility in the future to adjust a bioactive function via processing.
Keywords: bioactive peptides, processing, bioavailability, bioactive function, dairy 
products
1. Introduction
Dairy products are appreciated for their high nutritional value [1]. Not only the high con-
tents of protein, vitamins, and minerals determine the positive health effect of dairy prod-
ucts. Hidden components called bioactive peptides, encrypted in parent milk proteins, exhibit 
special functions that might influence our well-being. So far peptides with antihypertensive, 
anti-oxidative, anti-thrombotic, anticancer, immune-modulatory, antimicrobial, cholesterol-
lowering, antidiabetic, mineral-binding, opioid and satiety properties were identified. These 
peptides occur directly in the dairy products after processing and are resistant to diges-
tion enzymes or they are encrypted in dairy proteins and get released during digestion. 
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Interestingly, the processing method of the dairy products can influence the number and 
sequence of the resulting peptides after digestion and therefore also the content of bioactive 
peptides. Heat treatment, chemical and biochemical, and physical treatment can influence 
the bioactive functionality transmitted by the selected dairy product. In the future, it might 
be possible to target a wished bioactive function via processing. This book chapter just deals 
with the effects exhibited by bioactive peptides. However, also other milk components are 
affected by processing and can exhibit bioactive functions, e.g. effects on the lipids, minerals, 
and vitamins. Furthermore, the addition of certain bioactive ingredients to dairy products is 
also not discussed in this chapter. The focus is given to the possible effects transmitted via 
bioactive peptides and the effect of processing on the peptide profile.
2. Bioactive peptides and their functionalities
The health potential of dairy protein is not only originating from the unique amino acid com-
position and their great bioavailability (Figure 1). Especially the high content of essential 
amino acids and their fast release as free amino acids during digestion [2], plus the high 
content of certain vitamins and minerals is important for the high nutritional value of bovine 
milk. However, there is a more hidden health potential of dairy products that is displayed 
by bioactive peptides. Bioactive peptides contain usually 3–20 amino acid residues and 
their composition and sequence determine their activity. They are encrypted in the primary 
sequence of proteins and get released via three different ways [3]:
1. Hydrolysis by digestive enzymes
2. Hydrolysis by proteolytic microorganisms
3. Action of proteolytic enzymes derived from microorganisms or plants
Figure 1. Illustration of milk protein degradation by lactic acid bacteria (LAB) and during digestion via digestive enzyme 
action resulting in bioactive peptides.
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These are the ways to produce bioactive peptides that can be afterwards purified and used 
as ingredients for manufacturers of functional foods. However, also the more natural way 
of processing via hydrolysis by proteolytic microorganisms can be an approach to enrich a 
specific bioactive function in a product. Bioactive peptides have been discovered not only in 
dairy products, but also in meat, eggs, fish, and other marine organisms and also in plant 
sources like certain grains, legumes, pulses, and oilseeds [4–6].
The production of bioactive peptides for use as additives can be done by enzymatic hydro-
lysis or microbial fermentation [7]. Enzymatic hydrolysis applies digestion enzymes. Mostly 
trypsin, a pancreatic proteinase is used, but also chymotrypsin, pepsin thermolysin, pancre-
atin, elastase, carboxypeptidase or a proline-specific endopeptidase can deliver bioactive 
peptides. Additionally, proteases from bacteria, fungi, and plants also showed interesting 
properties [7]. Microbial fermentation uses bacteria or yeast that exhibit proteolytic activity 
to generate peptides. They are grown and added in their exponential phase to the protein of 
interest. The degree of hydrolysis is then dependent on the strain and its proteolytic activity. 
In both ways, a purification of the peptides is necessary. This can be for example reached by 
centrifugation methods, freeze drying, desalting, and membrane filtration techniques [8]. 
Examples are the production of caseinophosphopeptides from α-s-casein with an immobi-
lized trypsin in a fluidized bed bioreactor [9] and a combination of diafiltration and anion-
exchange chromatography [10]. The peptide additives can be added to a product of interest 
to generate a functional food. For this purpose, also the stability of the peptides with regard 
to pH, temperature, and food matrix has to be considered. Furthermore, the more natural 
way to enhance dairy products with bioactive peptides is to directly add a bacterial culture 
to the dairy product and generate a fermented product containing bioactive peptides. This 
is the general processing method applied already for each fermented dairy product. If pro-
tein is not taken out, all dairy products result in a high quantity of bioactive peptides that 
might be absorbed in the small intestine. For the functionality of these peptides, the selec-
tion of bacteria strains is important to aim for a specific bioactive function via processing 
(see Section 3).
The possible, so far detected, functionalities of bioactive peptides are summarized in Figure 2.
Figure 2. Possible functionalities of bioactive peptides.
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2.1. Antihypertensive peptides
Antihypertensive peptides can inhibit the angiotensin I-converting enzyme (ACE) (EC 
3.4.15.1;ACE) that is involved in blood pressure regulation. ACE increases the blood pressure 
by converting angiotensin I into the vasoconstrictor angiotensin II and additionally degrades 
vasodilative bradykinin. ACE-inhibitory peptides were detected in different food proteins like 
bovine casein and human casein, whey protein, zein, gelatin, yeast, and corn [11]. The most 
ACE-inhibitory peptide in studies of [28], had an IC
50
 value of 77 μM and was originating from 
α-lactalbumin with the peptide sequence α-lactalbumin f(104–108). Different studies showed the 
bioavailability of the ACE-inhibitory peptides Ile-Pro-Pro and Val-Pro-Pro in humans [12, 13]. 
These two tripeptides are the ones that are studied the most and show the highest evidence for 
their bioefficacy.
2.2. Anti-oxidative peptides
Anti-oxidative peptides help against the oxidative damage caused by reactive oxygen species. 
The amino acids cysteine, lysine, histidine, methionine, tryptophan, and tyrosine can act as 
radical scavengers [14]. Therefore, they act as potential antioxidants.
2.3. Antithrombotic peptides
The formation of blood clots can be reduced by antithrombotic peptides. Especially known is 
the glycomacropeptide (GMP) originating from kappa-casein after enzymatic milk coagula-
tion. GMP can inhibit the aggregation of blood platelets and binding of the human fibrino-
gen gamma-chain to platelet surface fibrinogen receptors [15]. Also, the absorption into the 
plasma could be observed in humans for 2 anti-thrombotic peptides [16].
2.4. Anticancer peptides
Anticancer peptides can inhibit cancer cell growth. In vitro experiments with HL-60 human 
leukemia cells showed for example, that after skimmed milk digestion with a proteolytic 
enzyme from yeast Saccharomyces cerevisiae apoptosis can be induced [17].
2.5. Immune-modulatory peptides
Immune-modulatory peptides are mostly found in dairy products. Enzymatic hydrolysis 
resulted in a number of biologically active peptides that can influence immune cells and 
release specific signals [18]. Some peptides can stimulate or inhibit immune responses and 
their positive health effects have been investigated mostly in vitro. These assays are per-
formed with immune cells and target for example proliferation, phagocytosis, differentiation, 
and cytokine production. A survey of these assays can be found in the review of Maestri et al. 
[6]. The immunomodulatory potential of peptides originating from whey protein is discussed 
in the study of Gauthier et al. [19]. Interestingly, there are some in vivo studies that have 
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demonstrated promising results. Otani et al. showed for example that feeding mice a dietary 
casein phosphopeptide influenced the level of serum IgA and intestinal antigen-specific IgA 
[20]. The exact mechanism of the action exhibited by immune-modulatory peptides still has 
to be determined.
2.6. Satiety peptides
Peptides that inhibit dipeptidyl peptidase 4 (DPP-IV, EC 3.4.14.5) are known as satiety increas-
ing peptides. DPP-IV degrades the satiety regulating glucagon-like-peptide 1 [21]. Kopf-
Bolanz et al, monitored the fates of specific peptides with known satiety increasing action. 
They compared different dairy products and found the relative abundance of three potent 
DPP-IV inhibitory peptides deriving from β-casein. The best source for these peptides was 
Gruyere cheese. Two other peptides deriving from α-S1-casein were not detectable anymore 
after the pancreatic phase of the digestion [22]. Tryptophan seems to be an important amino 
acid in peptides that exhibit a DPP-IV inhibitory potential [23]. Three dipeptides contain-
ing tryptophan Trp-Arg, Trp-Lys, and Trp-Leu with half maximum inhibitory concentrations 
(IC
50
) < 45 μM could be detected in a study of Nongonierma and Fitzgerald that are potent 
inhibitors of DPP-IV [24].
Another interesting peptide that has an influence on satiety is the glycomacropeptide (GMP) 
resulting from cheese production. It has demonstrated in several animals and human stud-
ies that it can stimulate the release of cholecystokinin and promote satiety. However, further 
studies would be necessary to demonstrate a clear bioefficacy [25, 26]. Peptides that increase 
the satiety are also known as anti-obesity peptides [27].
2.7. Opioid peptides
Peptides that have an affinity for the opioid receptor are categorized in this group. There 
are receptors that are responsible for specific physiological effects like emotional behavior 
and food intake. Opioid peptides have the same N-terminal sequence Tyr-Gly-Gly-Phe. 
There are also atypical opioid peptides with the ending of Tyr-X-Phe or Tyr-X1-X2-Phe. A 
tyrosine residue at the N-terminal and another aromatic amino acid at the third or fourth 
position are specific binding motifs of the opioid receptor. The first food-derived opioid 
peptides were β-casomorphins. Also, casoxins, lactorphins, and exorphins can bind to opi-
oid receptors [28]. So far, a weak opioid activity for α-lactorphin (α-lactalbumin f(50–53)) 
and β-lactorphin (β-lactoglobulin f(102–105)) was detected in guinea pigs [11], but human 
data are still missing. Concentrations released from in vivo digestion of milk are quite low. 
The total amount of α-lactorphin and β-lactorphin in 1 L of bovine milk would be 32 mg 
(64 μmol), respectively 90 mg (162 μmol), but it might be difficult to obtain a full release 
of the possible peptide during in vivo digestion. It is so far not clear whether they can get 
liberated by in vivo digestion at all, but it was demonstrated that casomorphins are liber-
ated in vivo [11].
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2.8. Antidiabetic peptides
Diabetes is treated by synthetic antidiabetic drugs that can result in side effects like hypo-
glycemia or weight gain [8]. To overcome this issue, the application of antidiabetic peptides 
originating from food sources might be a solution. Antidiabetic peptides could be for example 
detected in sheep milk [29].
2.9. Mineral-binding peptides
Mineral-binding phosphopeptides can carry different minerals by forming soluble organophos-
phate salts [30]. Caseinophosphopeptides (CPP) can increase calcium absorption by limiting cal-
cium precipitation in the ileum. Caseins are phosphorylated in the mammary gland at primary 
sequences rich in serine and glutamic acid forming triplet regions SerP-SerP-SerP-Glu-Glu that 
occur in α-S1-casein (66–70), α-S2-casein (8–12), (56–60), (129–133) and β-casein (15–19). The 
presence of CPPs has been shown in vivo. Several animal studies have demonstrated the effect 
of CPP to enhance calcium bioavailability. In contrast, convincing results from human are still 
missing [31]. A human study with CPP-enriched preparations (containing candidate functional 
food ingredients) on calcium absorption from a calcium lactate drink showed no significant 
results [32]. Another interesting peptide is lactoferricin consisting of 25 amino acid residues. 
The molecule is folded into two globular units, each capable of binding one ferric (Fe3+) ion [33].
2.10. Cholesterol-lowering peptides
So far mainly peptides derived from soy proteins have been shown to suppress cholesterol in 
the blood. Some can for example target the cholesterol receptor or suppress the presence of 
LDL. Important for the functions are mainly the hydrophobic residues [34]. A novel peptide 
(Ile-Ile-Ala-Glu-Lys) from a trypsin-treated hydrolysate of β-lactoglobulin showed a hypo-
cholesterolemic effect in an animal study [35].
2.11. Antimicrobial peptides
Peptides that induce for example the lysis of bacterial membranes are antimicrobial peptides. 
They could be detected in α-lactalbumin, β-lactoglobulin, all casein fractions, and lactoferrin [36].
2.12. Safety issues
The safety and toxicity of bioactive peptides has to be considered. Different studies dem-
onstrated that casein hydrolysates and Val-Pro-Pro from powdered fermented milk did not 
show any toxicological potential [37–39]. Processing can lead to Maillard reaction and result 
in the production of allergenic compounds [40]. Processing changes the protein structure and 
might influence the protein degradation and therefore also the response of the immune sys-
tem. Therefore, it is important to determine the allergic potential that can arise from bioactive 
peptides. If fermentation takes place, for example, de novo peptides might originate and their 
allergenic potential has to be determined. First, a comparison with already known allergenic 
sequences can be done, followed by laboratory tests. The problem is that allergenic sequences 
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can occur over the whole dairy protein sequences, and there can be rare cases that people are 
allergic to a new peptide sequence arising from fermentation. However so far, mostly positive 
reports about the effect of fermentation are published [41, 42]. It is also important to mention 
that these functionalities were observed to a great extent with in vitro methods. Only very few 
human studies have demonstrated an effect of bioactive peptides in vivo.
2.13. Physiology of digestion
To exhibit really a bioactive function in vivo, the peptides must be released during digestion 
from their originating protein or if they are already in the product as such, they have to be resis-
tant to digestion enzymes. During digestion, the proteins get denatured by gastric acidification 
and subsequently degraded by pepsin and pancreatic peptidases like trypsin into peptides and 
amino acids. Furthermore, the final actions of the enzymes at the brush-border membrane in 
the small intestine have to be taken into account. There are peptidases that cleave amino acids 
or dipeptides from the N- or C-terminal of the interior bond of the oligopeptides. The mean 
size of the peptides in the jejunum considering the action of aminopeptidases and dipeptidases 
from the enterocytes is 3–6 amino acids. Di- and tripeptides can be transported actively by the 
peptide transporter PEPT1 [43]. Longer peptides can probably get absorbed ether via paracel-
lular or transcellular pathways. The possible transport of a heptapeptide was shown using a cell 
culture model [44]. In the blood, the peptides must be able to reach their target site in the periph-
eral organs. In a human study of van Platerink et al., 17 ACE-inhibiting peptides with 5–6 amino 
acids length could be detected in the blood after consumption of drinks enriched with those 
peptides [13]. The first proof that the tripeptide Ile-Pro-Pro does not undergo intestinal deg-
radation and can reach the circulation intact was shown from Foltz et al. [12]. Another human 
study showed the presence of a longer peptide after soybean consumption in the blood [45]. 
At the target cells, it is assumed that peptides can internalize via endocytosis and get digested 
in the lysosome. Peptides that do not enter target cells can accumulate in the liver and kidney 
and can be detected in urine or bile [6]. There is still the need to demonstrate a clear bioefficacy 
of the peptides and confirm the positive health effects in human studies. In the future possibly 
health claims for certain bioactive peptides could be developed. So far Japan declared certain 
antihypertensive peptides such as Val-Pro-Pro, Ile-Pro-Pro, Val-Tyr, and Cys-Pro-Pro as Food of 
Specific Health Use (FOSHU). In contrast, the European Food and Drug Association (EFSA) did 
not authorize any claims regarding the effect of bioactive peptides in foods yet [46].
2.14. Detection of bioactive peptides
Experiments concerning bioactive peptides are mainly done in vitro. Most of the time, a dairy 
product is inserted into an in vitro digestion model that mimics human digestion.
There are numerous in vitro digestion models that can be applied. It is important that a model 
close to human physiology and validated is applied. Recently, a harmonized digestion model 
was established during the COST digestion action. This model is very physiological and might 
be used for mimicking digestion [47]. The resulting peptides generated during the digestion 
process can be detected by peptidomic methods. Analytics of bioactive peptides aim toward 
three main directions [48]:
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1. Tracing the pathways of formation of bioactive peptides from the parent proteins
2. Identifying the biological properties
3. Improving the “positive” properties discovered in natural peptides by design of synthetic 
structural analogues or peptide mimetics
Peptidomics is the comprehensive qualitative and quantitative analysis of all peptides in a 
biological sample. In earlier days, protein digestion could be followed by HPLC or Edman 
sequencing [49]. Nowadays, MS-based techniques such as Liquid chromatography coupled 
to mass spectrometry (LC-MS) can be applied [22, 50]. Peptidomics of food hydrolysates, 
for example, led to the discovery of the exact sites of rennet cleavage on kappa-casein or the 
cleavage sites produced by bacteria during cheese ripening [49]. The detailed human study 
of Boutrou et al. was identified in the jejuna effluents of healthy adults, after consumption of 
30 g milk casein and whey proteins, 356 and 146 peptides [50]. The in vitro model developed 
by Minekus et al., almost resulted in similar peptides [47]. The different analytical approaches 
that can be applied are summarized in the review of Dallas et al. [49]. Technology allows the 
prediction of the peptide sequence and can generate a peptide fingerprint. The peptides can 
be then compared to the known bioactive peptides from the literature in various databases. 
An example is the milk bioactive peptide database by Nielsen et al. [51]. This database com-
prises information on bioactive peptides from across hundreds of original research articles 
and is available to the public. Furthermore, whole in silico strategies for bioactive function 
generation including computational modeling might be applied, that still have limitations, 
but might be used in the future for the design of new products.
3. Influence of processing on protein digestion and peptide profile
Dairy products are processed by the application of different physical and chemical meth-
ods. These methods change the protein structure irreversible or reversible depending on the 
impact of the treatment. The protein can be mainly denatured, hydrolysed, or glycosylated. 
This structural change can influence the access of the digestion enzymes to the protein and 
therefore changes the action of the digestion enzymes. An impact on the peptide profile that 
is generated before absorption into the blood takes place is the result. It is necessary to deter-
mine which processing methods and which processing variables are necessary to be able to 
reach or maintain a specific bioactivity.
3.1. Thermal treatment
Thermal processing is an important step to improve the microbial quality of milk. Additionally, 
enzyme activities are inactivated and some physicochemical changes can occur that might sup-
port processing. The nutritional value is greatly affected by thermal processing. Denaturation, 
β-elimination, racemization, or iso-peptide bond formation can occur that influence the nutri-
tional value [52]. Denaturation is influenced by pH, protein concentration, ionic environ-
ment, genetic variant, and presence of ligands [53]. Heating might even particularly destroy 
tryptophan, can convert Arginine into citrulline and ornithine, can deamidate glutamine and 
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asparagine, and desulphur cysteine and cysteine. Resulting end products might be lanthi-
onine, lysine-alanine, iso-peptides and ornitho-alanine [52]. The digestibility of whey pro-
teins increases after thermal treatment because the sites for enzymatic hydrolysis are easier 
to reach for the digestive enzymes. However, strong denaturation reduces digestibility [54]. 
Kopf-Bolanz et al. showed that heat treatment of dairy products led to an increased num-
ber of β-lactoglobulin peptides after in vitro digestion [22]. There is a greater susceptibility 
to hydrolysis following heat treatment [55]. Regarding the antidiabetic action of casein, there 
was a significant reduction observed after boiling compared to the raw casein [29]. The dena-
turation of whey protein via thermal processing led to an increase in the antibacterial activ-
ity of α-lactalbumin [56] and lysozyme [57]. The antioxidant action of whey proteins can be 
maintained by low-temperature processing. This results in high levels of specific dipeptides 
that can promote the synthesis of the antioxidant glutathione [58]. Extrusion cooking might 
also affect protein digestibility shown for example in a study of Onwulata et al. [59]. Data on 
the effect of ohmic heating are rare. Depending on the used temperatures, similar effects like 
with application of other heating methods might be expected [52]. It was also shown that spray 
drying or freeze drying did not exhibit negative effects on the immunomodulatory activity of a 
whey protein hydrolysate. The study also used whey protein concentrate (WPC) and sodium 
alginate as carriers for encapsulation to reduce bitter taste and resistance to hygroscopicity. 
They showed that spray drying of whey protein concentrate hydrolysate with the proper car-
riers did not affect the immunomodulatory activity and might therefore widen its application 
in food systems [60].
3.2. Chemical treatment
Hydrolysis by acid is applied which is known to improve their protein digestibility. It is used 
for example for enteral and hypoallergenic infant nutrition. For Mozzarella, the type of acid 
used is important for the protein yield obtained in the pre-cheeses [61] and might therefore also 
affect the profile of bioactive peptides. Treatment with alkali for hydrolysis is rarely applied in 
the food industry. It would result in racemization and loss of protein digestibility [62].
3.3. Biochemical treatment
Fermented dairy products like yoghurt and cheese result in a high number of bioactive 
peptides produced by the lactic acid bacteria. Especially the type of the starter culture, type 
of probiotic bacteria, and the fermentation parameters play an important role for the bioac-
tive effect that the product might have. Furthermore, only via this way de novo peptides 
can be generated that do not occur after digestion of milk as such. Streptococcus thermophi-
lus and Lactobacillus bulgaricus possess bacterial activity against Streptococci in vivo that 
probably derives from the antimicrobial peptides that they produce during fermentation 
[63]. It is very promising to test different lactic acid bacteria strains for their effect on a bio-
active function. One study of Gobbetti et al. showed that a fermentation with L. delbrueckii 
ssp. Bulgaricus SS1 versus a fermentation with Lactobacillus lactis subspecies cremoris FT4 
resulted in a higher ACE-inhibitory activity [64]. The most investigated ACE-inhibitory 
peptides were obtained after fermentations with L. helveticus and L. helveticus CP790. Also, 
the Finnish milk product Evolus contained L. helveticus LBK-16H strain as a starter and 
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they all contained the tripeptide IPP and exerted a hypertensive effect [65–67]. Another 
study demonstrated the effect of the time of cheese ripening on the ACE-inhibitory activ-
ity. Cheese was produced with a mixture of 12 different strains and showed an increase 
of the inhibitory effect during ripening as long as a certain level of proteolysis was not 
exceeded [68]. In 10 Swiss cheese types, the ACE-inhibiting peptides V-P-P and I-P-P were 
quantified. They detected contents of 19.1 mg/kg to 182.2 mg/kg depending on the cheese 
type that shows the huge effect of different processing ways probably via different lactic 
acid bacteria [69]. Also, the application of new techniques like next-generation sequencing 
that reveals the whole genome of bacteria strains might help to select promising strains 
with specific protease expressions. It was also demonstrated that fermentation reduced the 
allergenic potential of α-lactalbumin and β-lactoglobulin [41, 42]. The peptides that result 
after fermentation and enzyme hydrolysis might remain susceptible to further hydroly-
sis as long as the process goes on. This might lead to a decrease of bioactive function 
of these peptides. More important is also the stability of the generated peptides. They 
might be degraded by the digestive enzymes and result in zero activity in the body. The 
stability versus the action of gastric and pancreatic enzymes has to be tested beforehand. 
Another problematic point is that the microbial fermentations have to be reproducible [8]. 
Fermentation with known and established lactic acid bacteria cultures is a great strategy 
to enrich certain bioactive peptides with a special functionality. This would be a possibil-
ity to enhance a bioactive function in a natural way with a minimal processing approach 
that meets the interests of the consumer. The functionality and bioavailability of bioactive 
peptides generated via fermentation has to be more clarified.
The use of milk-clotting enzymes and digestive enzymes to produce bioactive peptides is 
another processing approach. However, most of the resulting peptides had a bitter taste 
[7]. Membrane-separation technique is applied to enrich peptides with a specific molecular 
weight [3]. It was also shown that hydrolysed infant formulas show a different peptide profile 
compared to the standard formulas assuming that infants fed hydrolysed formulas might 
obtain bioactive peptides that promote other bioactive functions than the ones provided by 
the standard formulas [70].
3.4. Physical treatment
Homogenization applies pressure (14–18 MPa) and shear stress that alter the protein struc-
ture and improve the digestibility [52]. Use of ultra-high pressure homogenization with pres-
sure around 400 MPa results in more severe protein denaturation [71]. Application of high 
hydrostatic pressure processing increased digestibility of β-lactoglobulin with pepsin with 
increasing pressures (400–800 MPa) [72]. Penas et al. also combined high hydrostatic pressure 
processing with selected food-grade proteases and demonstrated a reduction in antigenicity 
of the whey protein hydrolysates that can be used as ingredients of hypoallergenic infant 
formulae [73]. Ultrasound treatment is a non-conventional processing technique that can 
denature α-lactalbumin and β-lactoglobulin. In whole milk compared to skim milk, the dena-
turation was stronger and heat addition even increased this effect [74]. A very soft technology 
is membrane filtration that enables to separate proteins in their native state. This technology 
only enables a fractionation of different milk components and does not alter the protein struc-
ture as such, and it only influences the milk composition.
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4. Influence of other factors on bioavailability of bioactive peptides
Not only processing can influence the profile of bioactive peptides. Also, other external factors 
can influence protein digestion and therefore the bioavailability and generation of bioactive 
peptides. It is important to consider the effect of the food matrix and meal composition on 
digestion. For example, the addition of inulin to the dairy product can influence digestion 
and peptide bioavailability [75]. Also, proteins can form complexes with polyphenols, etc. that 
could lower protein bioavailability [76]. Furthermore, internal factors can influence the peptide 
profile. Children and the elderly have different enzyme activities and therefore the digestion 
enzymes will act slightly different and change the peptide profile [77, 78]. Genetic variations in 
people for example enzyme deficiencies or changes in the composition of the digestion juices 
due to different transporter expression can have an impact. The action of digestion enzymes 
depends on daytime, age and on Helicobacter pylori infection [79]. Also for a lot of other spe-
cial physiological states, certain diseases and so on, the enzyme activity is affected and might 
therefore result in a different bioactive peptide bioavailability. It is very important to consider 
all the factors that can affect peptide bioavailability in the target group of the product.
5. Possible approach for design of a dairy product with a satiety 
increasing effect
An enrichment of peptides that can inhibit DPP-IV could result in increasing satiety after con-
sumption of a dairy product. The most promising approach to steer the peptide profile of the 
Figure 3. Targeting bioactive function in product development.
Adjusting Bioactive Functions of Dairy Products via Processing
http://dx.doi.org/10.5772/intechopen.72927
119
product is via fermentation with lactic acid bacteria. It would be promising to test different starter 
bacteria with different protease activities. Differences in their proteolytic action result in differ-
ent peptide profiles. Then, an in vitro digestion model might be applied that is mimicking the 
digestion physiology of the target group. Next step would be peptide profiling and alignment 
of the results with already known sequences of DPP-IV inhibitory peptides. Furthermore, the 
inhibitory effect could be also tested using directly an enzyme assay. It is important to consider 
also all the other processing parameters that can affect protein digestion. Finally, the bioactive 
effect has to be confirmed in humans that represent the target group of the product (Figure 3).
6. Conclusion
After ingestion of food containing protein, a peptide pattern is generated that probably contains 
bioactive sequences and is present in the jejunum before absorption takes place. Especially for 
dairy products, many different bioactive peptides could be identified that might be very inter-
esting for the development of products with a specific functionality. The peptide patterns are 
strongly influenced by processing. Thermal treatments are used in general to ensure the micro-
bial quality of dairy proteins. They exhibit a great influence on the protein structure for example 
by protein unfolding. Easier access is then given to the digestion enzymes and the resulting 
peptide profile is changed. Highly interesting is the fermentation of dairy products with differ-
ent lactic acid bacteria strains. Certain strains have different protease activities and increase for 
example the number of antihypertensive peptides resulting after digestion. The angiotensin-
converting enzyme inhibition is the most studied functionality and there are reports that could 
detect bioavailable peptides in the blood. The peptide concentrations reached for example in 
cheeses are promising to exhibit a bioactive function. Chemical and physical approaches can also 
influence the protein structure and therefore the protein digestion. The impact of new process-
ing techniques on protein digestion should be always monitored. For the adjustment of a specific 
bioactive function in a product, an example approach is mentioned. However, it will always 
also depend on other factors whether the wished functionality is really reached or not. External 
factors like the meal composition and internal factors like age or genetic preconditions can also 
have an impact and have to be considered. Furthermore, for safety reasons, there is the small 
chance that generated de-novo peptides might act as epitopes for rare cases of cow milk allergy. 
However so far, fermentation with established lactic acid bacteria strains seems to reduce the 
allergenic potential of dairy products in general. In the future, it is necessary to perform well 
designed human studies that ensure a bioactive effect and allow the admission of health claims.
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